Nasdaq Stockholm

Xvivo Perfusion Aktiebolag

ISIN SE0004840718Filings at the FI

At a glance

Most recent filing on July 22, 2026 — an open-market purchase by Emil Billbäck on Jul 21, 2026.

We hold 59 visible filings, going back to February 11, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 59 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 59. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Emil Billbäck Board member
387,419 SEKOpen-market buy
TradedJul 21, 2026FiledJul 22, 2026
Emil Billbäck Board member
473,251 SEKOpen-market buy
TradedJul 21, 2026FiledJul 22, 2026
Kristoffer Nordström Chief financial officer
54,300 SEKOpen-market buy
TradedMar 20, 2026FiledMar 20, 2026
Kristoffer Nordström Chief financial officer
42,425 SEKOpen-market buy
TradedDec 3, 2025FiledDec 4, 2025
Kristoffer Nordström Chief financial officer
42,450 SEKOpen-market buy
TradedDec 3, 2025FiledDec 4, 2025

Short positions

All short positions

Net short positions of 0.5% or more in Xvivo Perfusion Aktiebolag that are open today, as the regulator publishes them. Together they come to 4.86% of the shares. Positions below 0.5% are not published, so the real total can be higher.

5 open positions, together 4.86%. The holders and their history are part of the subscription.

Källa: Finansinspektionen, October 31, 2026.